
IHI and IMI projects are enhancing the environment in Europe for conducting clinical trials by connecting relevant sites and experts, investigating new trial designs and protocols...
IHI and IMI projects are enhancing the environment in Europe for conducting clinical trials by connecting relevant sites and experts, investigating new trial designs and protocols...
The new project focuses on respiratory syncytial virus (RSV), an infectious disease that can cause severe illness in young children and other vulnerable groups.
Dr Blomberg has worked in both research and leadership roles in Europe's life sciences sector, and is currently Director of ELIXIR, the life sciences data infrastructure.
Addressing cancer and neurodegenerative diseases, and bringing on board sectors as diverse as pharmaceuticals, medical technology, big data and imaging, the projects exemplify IHI...
IHI builds on the successes of earlier European public-private partnerships in health research and innovation.
Through the States Representatives Group (SRG), Member States provide vital input into the direction of IHI, as SRG chair Martha Cahill explains in this interview.